
Cap 1 N1meψ ABE8e_P2A_GFP mRNA
ABE8e revolutionizes adenine base editing, overcoming previous limitations with its enhanced compatibility and efficiency. Evolved from ABE7.10 using innovative methods like PANCE and PACE, ABE8e features eight additional mutations, boosting activity by 590-fold. Its compatibility extends beyond SpCas9, offering improved editing efficiencies with various Cas9 or Cas12 homologs. ABE8e’s enhanced processivity enhances applications like screening, regulatory region disruption, and multiplex base editing. This mRNA possesses a Cap1 structure, which is highly efficient in capping. It is fully substituted with N1-methyl-pseudo Uridine to improve expression and decrease immunogenicity. Additionally, the mRNA features a 110A tail in its sequence, resembling a mature mRNA.